[{"Assets_0_FY_USD":118112000.0,"CommonStockSharesOutstanding_0_FY_shares":44014040.0,"NetIncomeLoss_4_FY_USD":-28159000.0,"NetIncomeLoss_1_FY_USD":-5272000.0,"StockholdersEquity_0_FY_USD":53582000.0,"Assets_0_Q1_USD":100275000.0,"CommonStockSharesOutstanding_0_Q1_shares":45094154.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-12210000.0,"NetIncomeLoss_1_Q1_USD":-1205000.0,"StockholdersEquity_0_Q1_USD":56008000.0,"Ticker":"CDMO","CIK":"704562","name":"PEREGRINE PHARMACEUTICALS INC","OfficialName":"Avid Bioservices Inc. Common Stock","form":"10-K","period":"20170430","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1130539049.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170911"}]